It is characterized by increased circulating levels of FGF23, which leads to hypophosphatemia and suppression of vitamin D 1α-hydroxylase (Cyp27b1), resulting in decreased production of 1,25-dihydroxyvitamin D3 (1,25D) (6–8). Here, CYP27B1 is linked to hypophosphatemia.